Ximelagatran, and the pharmaceutically acceptable salts thereof (exanta).

摘要

There is provided the combination of acetylsalicylic acid and a compound of the general formula I A1 - A2 - NH - (CH2)n - B wherein A1, A2, n and B have meanings given in the description, for use in therapy.